Study on Zenocutuzumab (MCLA-128) for Patients with Solid Tumors with NRG1 Fusion | Clinical Trial

Study on Zenocutuzumab (MCLA-128) for Patients with Solid Tumors with NRG1 Fusion | Clinical Trial | Right2Hope